Paul Hafey

Paul Hafey joined the Company as Vice President, Research and Development in 2008 with more than twenty nine years of experience in pharmaceutical operations, quality and research. He was promoted to his current position in October 2016. He received his Bachelor of Arts degree in Chemical Laboratory Administration from Capital University in Columbus, Ohio. He also holds an Associate of Arts degree from The Ohio State University.

Paul began his career as a laboratory technician at Roxane Laboratories, ultimately progressing to Section Head of Quality Assurance and gaining a strong operations background covering laboratory, quality assurance and production functions. He then moved to UCB Pharmaceuticals (formerly Medeva and Celltech) where he oversaw various research and development groups as Manager, Associate Director and Director. During that time, Paul was responsible for numerous functional areas including pre-formulation, formulation, process development, method development and method transfer. He has extensive experience in global product development, product evaluation and protection of intellectual property.

As President of Sovereign, Paul's expertise and experience are assets that help him direct resources effectively, he not only provides oversight of the firm's CGMP capabilities and NDA/ANDA projects but also manages the organizational and ancillary issues that these capabilities and projects require as the Company continues its expansion.‍